Sun, Dec 28, 2014, 6:22 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.


  • traderneal traderneal Aug 14, 2012 4:27 PM Flag

    It is a pleasure being short this stock...

    I have been short with an avg cost of about $3.25 since that bogus press release. (My only regret was shorting it that night of the press release and not the next day, so I took some pain).

    That press release was specifically designed to make the avg investor believe that SBUX was going to carry CRMB's products. It actuallity, it was the other way around. Big Deal.

    Now tonight, the truth comes out in the form oh HORRIBLE earnings. Thiey missed revenues by $8mm or over 40%. EPS numbers were also a nightmare.

    I would love to know who ran the stock up in the last half hour, but they are paying for it now, as CRMB is now down almost 20% from the close.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Further co said beverage sales make up 10% of revenue and most they are hoping for with SBUX agreement is to up that to 15 or at the most 20% of revenue.Also cannot sell SBUX Frappuccino.Not a game changer by any means.Now you need to price in steep price of heavy dilution in strategic plan of expansion.Still trading 30% higher than when SBUX pr was released.Still a good short as any turnaround is at least a year away and highly doubt they can pull it off.

      • 1 Reply to brucem2004
      • I think you're missing the point about the Starbucks opportunity. The upside potential isn't so much from selling more coffee, but rather from selling more cupcakes due to increased traffic. They have very good margins on their cupcakes, so even a realtively small and steady increase in same-store sales could lead to good profitability in the long term.

        With that said, I am also concerned about the potential dilution.

0.270.00(0.00%)Jul 14 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST
PG&E Corporation
NYSEFri, Dec 26, 2014 4:02 PM EST